Recombinant Human Laforin Expressed in Insect Cells: Expression, Purification, and Biochemical Characterizations
![]() |
Choi, Ji-Woong
(Biomolecular Function Research Branch, Division of Convergence Technology, National Cancer Center)
Bong, Seoung Min (Biomolecular Function Research Branch, Division of Convergence Technology, National Cancer Center) Yang, Seung Won (Biomolecular Function Research Branch, Division of Convergence Technology, National Cancer Center) Jang, Hyonchol (Division of Cancer Biology, Research Institute, National Cancer Center) Park, SangYoun (School of Systems Biomedical Science, Soongsil University) Kim, Seung Jun (Medical Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnology) Lee, Byung Il (Biomolecular Function Research Branch, Division of Convergence Technology, National Cancer Center) |
1 | Minassian, B. A.; Lee, J. R.; Herbrick, J. A.; Huizenga, J.; Soder, S.; Mungall, A. J.; Dunham, I.; Gardner, R.; Fong, C. Y.; Carpenter, S.; Jardim, L.; Satishchandra, P.; Andermann, E.; Snead, O. C., 3rd; Lopes-Cendes, I.; Tsui, L. C.; DelgadoEscueta, A. V.; Rouleau, G. A.; Scherer, S. W., Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat. Genet. 1998, 20(2), 171. DOI |
2 | Brewer, M. K.; Husodo, S.; Dukhande, V. V.; Johnson, M. B.; Gentry, M. S., Expression, purification and characterization of soluble red rooster laforin as a fusion protein in Escherichia coli. BMC biochemistry 2014, 15(1), 8. DOI |
3 | Jarvis, D. L., Baculovirus Expression Vectors. In The Baculoviruses; Plenum Press: New York, 1997, Miller, L.K., Ed.; pp 389-431. |
4 | Roma-Mateo, C.; Solaz-Fuster Mdel, C.; Gimeno-Alcaniz, J. V.; Dukhande, V. V.; Donderis, J.; Worby, C. A.; Marina, A.; Criado, O.; Koller, A.; Rodriguez De Cordoba, S.; Gentry, M. S.; Sanz, P., Biochem. J. 2011, 439(2), 265. DOI |
5 | Raththagala, M.; Brewer, M. K.; Parker, M. W.; Sherwood, A. R.; Wong, B. K.; Hsu, S.; Bridges, T. M.; Paasch, B. C.; Hellman, L. M.; Husodo, S.; Meekins, D. A.; Taylor, A. O.; Turner, B. D.; Auger, K. D.; Dukhande, V. V.; Chakravarthy, S.; Sanz, P.; Woods, V. L., Jr.; Li, S.; Vander Kooi, C. W.; Gentry, M. S., Mol. Cell 2015, 57(2), 261. DOI |
6 | Wang, J.; Stuckey, J. A.; Wishart, M. J.; Dixon, J. E., A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen. J. Biol. Chem. 2002, 277(4), 2377. DOI |
7 | Cantarel, B. L.; Coutinho, P. M.; Rancurel, C.; Bernard, T.; Lombard, V.; Henrissat, B., The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics. Nucleic Acids Res. 2009, 37 (Database issue), D233. DOI |
8 | Ganesh, S.; Tsurutani, N.; Suzuki, T.; Hoshii, Y.; Ishihara, T.; Delgado-Escueta, A. V.; Yamakawa, K., The carbohydratebinding domain of Lafora disease protein targets Lafora polyglucosan bodies. Biochem. Biophys. Res. Commun. 2004, 313(4), 1101. DOI |
9 | Tonks, N. K., Protein tyrosine phosphatases: from genes, to function, to disease. Nature Reviews. Mol. Cell Biology 2006, 7(11), 833. |
10 | Alonso, A.; Sasin, J.; Bottini, N.; Friedberg, I.; Friedberg, I.; Osterman, A.; Godzik, A.; Hunter, T.; Dixon, J.; Mustelin, T., Protein tyrosine phosphatases in the human genome. Cell 2004, 117(6), 699. DOI |
11 | Tagliabracci, V. S.; Heiss, C.; Karthik, C.; Contreras, C. J.; Glushka, J.; Ishihara, M.; Azadi, P.; Hurley, T. D.; DePaoliRoach, A. A.; Roach, P. J., Phosphate incorporation during glycogen synthesis and Lafora disease. Cell Metab. 2011, 13(3), 274. DOI |
12 | Girard, J. M.; Le, K. H.; Lederer, F., Molecular characterization of laforin, a dual-specificity protein phosphatase implicated in Lafora disease. Biochimie 2006, 88(12), 1961. DOI |
13 | Dukhande, V. V.; Rogers, D. M.; Roma-Mateo, C.; Donderis, J.; Marina, A.; Taylor, A. O.; Sanz, P.; Gentry, M. S., Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activity. PloS one 2011, 6(8), e24040. DOI |
14 | (a) Gentry, M. S.; Roma-Mateo, C.; Sanz, P., Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii. The FEBS Journal 2013, 280(2), 525; DOI |
15 | (b) Gentry, M. S.; Dixon, J. E.; Worby, C. A., Lafora disease: insights into neurodegeneration from plant metabolism. Trends Biochem. Sci. 2009, 34(12), 628. DOI |
16 | Ganesh, S.; Puri, R.; Singh, S.; Mittal, S.; Dubey, D., Recent advances in the molecular basis of Lafora’s progressive myoclonus epilepsy. J. Hum. Genet. 2006, 51(1), 1. DOI |
17 | Tagliabracci, V. S.; Turnbull, J.; Wang, W.; Girard, J. M.; Zhao, X.; Skurat, A. V.; Delgado-Escueta, A. V.; Minassian, B. A.; Depaoli-Roach, A. A.; Roach, P. J., Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(49), 19262. DOI |
![]() |